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Surface modiﬁed Eu:GdVO4 nanocrystals for optical
and MRI imaging†
Nuria O. Nuñez,*a Sara Rivera,b David Alcantara,b Jesus M. de la Fuente,b
Jorge García-Sevillanoc and Manuel Ocañaa
A facile solvothermal route has been developed for the preparation of europium doped gadolinium
orthovanadate nanoparticles (∼70 nm) with tetragonal structure, based on a homogenous precipitation
reaction at 120 °C from rare earth precursors (yttrium nitrate and europium nitrate) and sodium ortho-
vanadate solutions using an ethylene glycol–water mixture as the solvent. The eﬀects of the doping level
on the luminescence properties were evaluated in order to ﬁnd the optimum nanophosphors. These
nanocrystals were successfully functionalized with amino (two step process) and carboxylate (one-pot
process) groups provided by amino-dextran polymers (AMD) and polyacrylic acid (PAA), respectively. It
was found that while the luminescent properties of both kinds of functionalized systems were similar,
the colloidal stability of the PAA-modiﬁed sample was higher, because of which, it was selected to study
their cytotoxicity and magnetic properties (relaxivity and phantom analyses) to assess their potentiality as
multifunctional probes for both “in vitro” optical biolabels and negative contrast agents for magnetic
resonance imaging.
1. Introduction
Nowadays, much attention has been paid in the biomedical
field to the development of multifunctional nanoparticles suit-
able for both, optical and magnetic resonance (MRI) imaging
applications1 because they combine the high sensitivity of
optical imaging for in vitro applications with the excellent
spatial resolution and depth for in vivo application associated
with the MRI imaging.1c,d,g,h A large variety of compositions
have been proposed. For example, the optical functionality
may be aﬀorded by quantum dots,1b fluorescent dyes,1b,2 or
rare earth based compounds,1c–j,3 the latter being preferred
due to their lower toxicity and higher photostability.4 For the
MRI functionality, the most frequently used contrast agent is
superparamagnetic iron oxide,1b,g,2–5 although diﬀerent kinds
of nanoparticles containing Gd(III) ions have been also propo-
sed1f,h,j,6 taking advantage of the magnetic moment and nano-
second time scale electronic relaxation time of the Gd
cations.7 These Gd containing materials may consist of a
Gd(III) complex,8 a diamagnetic matrix doped with Gd cations1c
or Gd compounds such as GdPO4,
9 Gd2O3,
1a,d,j,6 GdF3,
7
NaGdF4,
1d,f,h,i to mention a few. Important benefits of using
nanoparticles of these Gd compounds instead of Gd(III) com-
plexes are a dramatic increase in the local Gd ion concen-
tration in the region of interest, easy functionalization, control
of targeting and release through their particle size, possibility
of improvement in relaxivities1h and easy doping with other
luminescent lanthanide (Ln) cations to obtain the optical
functionality.
Among the diﬀerent luminescent Gd compounds, those
based on Gd orthovanadate (GdVO4) are of special interest
from the optical point of view since the excitation of the
doping Ln cation through an energy transfer from the vana-
date anion is much more eﬃcient than the direct excitation of
the Ln electronic levels, which results in a higher lumines-
cence.10 It is outstanding that although several reports have
been published on the synthesis and optical properties of
Ln:GdVO4 nanoparticles having diﬀerent morphologies
(rods,11 spindles,12 and spheres)13,14 little attention has been
devoted to the assessment of their potentiality as multifunc-
tional materials for optical and MRI imaging. In fact, to the
best of our knowledge, only a few recently published
works10c,13b,14,15 report on the optical imaging ability, the mag-
netic relaxivity properties and the cytotoxicity of Ln:GdVO4
(Ln = Eu,10c Er/Ho/Tm + Yb13b,14 or Dy15 nanocrystals).
It is also well known that for most biotechnological appli-
cations, the modification of the nanoparticles surface with
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molecules of biological interest is an important issue since
they provide anchors for adding functional ligands such as
antibodies and drugs16 and aﬀect the colloidal stability of
nanoparticles suspensions as recently demonstrated for YVO4:
Eu nanoparticles,17 which are isostructural to those herein
studied. However, among the above-mentioned reports dealing
with Ln:GdVO4 nanoparticles, only that by Kang et al. was con-
ducted using poly(acrylic) acid functionalized GdVO4 spheres,
which were above the nanometric size range (180 nm) and
showed a rather irregular shape and a certain degree of aggre-
gation. Moreover, the colloidal stability of an aqueous suspen-
sion of such spheres was not addressed by these authors.
Therefore, the development of functionalization procedures
for GdVO4 based nanophosphors is still highly desirable.
In this work, we have developed simple methods for the
synthesis of uniform Eu-doped GdVO4 nanocrystals (70 nm)
with optimised luminescent properties, and their functionali-
zation with amino (two step procedure) and carboxylate (one-
pot procedure) groups provided by amino-dextran polymers
(AMD) and polyacrylic acid (PAA), respectively, in order to com-
paratively evaluate their colloidal stability in aqueous media
(pH = 6.95). In addition, the magnetic relaxivity of the
optimum functionalized nanophosphor was analysed through
phantom analysis and its cell viability evaluated to assess its
potentiality as a biolabel for in vitro applications and as MRI
contrast agents.
2. Experimental details
2.1. Materials
Gadolinium(III) nitrate hexahydrate (GdNO3·6H2O, Aldrich,
99.9%) and europium(III) nitrate pentahydrate (Eu(NO3)3·5H2O,
Aldrich, 99.9%) were selected as Ln precursors. Sodium ortho-
vanadate (Na3VO4, Aldrich, 99.9%) was used as a vanadium
source and a mixture of ethylene glycol (EG)–water as a
solvent. For functionalization, polyacrylic acid (PAA, average
Mw ∼ 1800, Aldrich) and amino-dextran synthesized polymers
were used.
For the amino-dextran (AMD) preparation,18 aldehyde-
dextran was first obtained by oxidation of 1.67 g of dextran
(average mol wt 15 000–30 000, Aldrich) dissolved in water
(50 cm3) with 0.8 g of sodium periodate (NaIO4, ≥99.0%,
Aldrich). The oxidation was performed overnight at room
temperature under magnetic stirring. Once the reaction was
finished, the solution was dialyzed against double distilled
water for 24 h using a dialysis tubing cellulose membrane. The
dextran obtained under these conditions has 20% of the
glucose molecules present in the polymer oxidized as di-alde-
hydes. The aldehyde-dextran so obtained was mixed first with
an equal volume of a 3 mol dm−3 tetraethylenepentamine
(TEPA, ≥98%, Sigma-Aldrich) solution at pH 7.5 (adjusted with
NaOH) and then with solid trimethylaminoborane (TMAB,
≥95%, Fluka) which was dissolved until its final concentration
reached 150 mM. After 15 h, the obtained amino-dextran was
reduced to stabilize the Schiﬀ’s bases formed and any
remaining aldehyde. For this purpose, 10 mg cm−3 of sodium
borohydride (NaBH4, ≥98.0% Aldrich) were first added to the
above solution after which the pH was adjusted to 10 by
adding NaOH. Then, sodium borohydride was added again in
a similar proportion (10 mg cm−3). This mixture was kept
under magnetic stirring for 2 h at room temperature after
which the pH of the mixture was lowered to 6 using hydro-
chloric acid (37%, Prolabo) to destroy the sodium borohydride
excess. Once the dextran was modified with TEPA and
reduced, it was dialyzed, first, against a sodium acetate
(>99.5%, Fluka) 10 mM solution at pH = 4 and then against
double distilled water (twice).
2.2. Nanoparticles synthesis
RE orthovanadate nanoparticles having diﬀerent Eu/Eu + Gd
atomic ratios (0.02, 0.05, 0.10, 0.15) were prepared according
to the following procedure. Suitable amounts of RE precursors
were dissolved in ethylene glycol (2.5 cm3). In a separate vial, a
weighed amount of Na3VO4 was dissolved in an EG–H2O
mixture (1.5 cm3 H2O + 1 cm
3 EG). To facilitate the dissolution
of reagents in EG the solutions were mildly heated (∼80 °C)
under magnetic stirring. After cooling down to room temp-
erature, both solutions were then admixed while keeping the
magnetic stirring. In the final solutions, the total RE and the
Na3VO4 concentrations were kept constant at 0.02 mol dm
−3
and 0.1 mol dm−3, respectively whereas the final EG–H2O volu-
metric ratio was 3.5 : 1.5. The so prepared solutions were then
aged for 3 h in tightly closed test tubes using an oven pre-
heated at 120 °C. After aging, the resulting dispersions were
cooled down to room temperature, centrifuged to remove the
supernatants and washed twice with ethanol and once with
distilled water. Finally, the precipitates were redispersed in
milliQ water or, for some analyses, dried at room temperature.
2.3. Functionalization with amino-dextran
For functionalization, solutions with adjusted pH (8–8.5) of
amino-dextran 20% oxidized (0.093 mmol dm−3) were first pre-
pared. Then, a weighed amount of the Eu0.10Gd0.90VO4 nano-
particles previously synthesized was added to such solutions
so that their final concentration was 0.2 mg cm−3. The result-
ing dispersions were sonicated in cold water during 1 h. After
this treatment, the so functionalized nanoparticles were
washed several times with milliQ water by centrifugation and
finally redispersed in milliQ water.
2.4. Functionalization with polyacrylic acid
The Eu-doped GdVO4 nanoparticles functionalized with PAA
were obtained following a protocol similar to that described
before for the synthesis of Eu-doped GdVO4 particles, which
was slightly modified by admixing 2 mg cm−3 of PAA into the
Na3VO4 starting solution.
2.5. Characterization
The shape of the nanoparticles was examined by transmission
electron microscopy (TEM, Philips 200CM). For this, a droplet
of an aqueous suspension of the samples was deposited on a
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copper grid coated with a transparent polymer and dried. The
particle size distributions were obtained from dynamic light
scattering (DLS, Zetasizer Nano ZS90, Malvern). The crystalline
structure of the prepared nanoparticles was identified by X-ray
diﬀraction (Siemens D501). The crystallite size was estimated
from the most intense XRD peak of the GdVO4 structure (2 0 0)
by using the Scherrer method.
The infrared spectra (FTIR) of the nanophosphors diluted
in KBr pellets were recorded in a Jasco FT/IR-6200 Fourier
transform spectrometer. Thermogravimetric analysis (TGA)
was performed in air at a heating rate of 10 °C min−1, using a
Q600TA Instrument. Z Potential measurements were carried
out in a Malvern Zetasizer Nano-ZS90 apparatus.
For a proper comparison of the luminescent properties of
these nanophosphors containing diﬀerent Eu doping levels,
all samples were dispersed in water at the same concentration
(0.2 mg cm−3) so that the absorbance of these dispersions in
the UV-visible region was similar. The excitation and emission
spectra of these samples were measured in a Horiba JobinYvon
spectrofluorimeter (Fluorolog FL3-11) operating with a slit of
1.5 nm. Lifetime measurements were obtained under pulsed
excitation at 532 nm by using the second harmonic of a
Nd:YAG laser (Spectra Physics model DCR 2/2A 3378) with a
pulse width of 10 ns and a repetition rate of 10 Hz. The fluo-
rescence was analysed through an ARC monochromator model
SpectraPro 500-i and then detected synchronously with an
EMI-9558QB photomultiplier and recorded by a Tektronix
TDS420 digital oscilloscope. The photographs showing the
luminescence of the nanophosphors in water dispersions were
taken under illumination with ultraviolet radiation (λ =
312 nm), filtered from a Hg discharge lamp.
1H NMR relaxation times T1 and T2 were measured
at 1.5 Tesla in a Relaxiometer (Bruker Minispec spectro-
meter) at diﬀerent concentrations of nanoparticles (0.1, 0.05,
0.025, 0.0125, 0.00625 mg cm−3) in water at 298 K. T1 and T2
values were determined by the inversion-recovery method and
by the Carr–Purcell–Maiboom–Gill sequence, respectively.
Images were post-processed using dedicated IDL 6.2 (Exelis
VIS Inc., Boulder, CA) software with homemade written scripts.
Relaxivities (r1, r2) were obtained from the slopes of the curves
1/T1 or 2 vs. the concentration of Gd(III) expressed in mM. Phan-
toms were obtained at 9.4 Tesla in a BrukerBiospec MRI.
The colloidal stability of nanoparticles suspensions (nano-
particle concentration = 0.5 mg cm−3) in milliQ water or in
50 mM MES solutions (2-(N-morpholino) ethanesulfonic acid,
Sigma, 99%) at pH 6.5 and in completed cell culture was moni-
tored by analyzing the evolution with aging time of their UV-
visible absorbance spectrum (UV/VIS Lambda 12 Perkin Elmer
spectrometer) and their hydrodynamic diameter obtained
from DLS measurements.
2.6. Cytotoxicity assay
Vero cell cultures (monkey kidney epithelial cells) were cul-
tured in Dulbecco’s Modified Eagle’s Medium (DMEM), sup-
plemented with 10% fetal bovine serum (FBS), 5% glutamine
(200 mM) and 5% penicillin (5000 units per mL)/streptomycin
(5 mg mL−1). Cell cultures were incubated at 37 °C and equili-
brated in 4% CO2 and air. Cell viability and proliferation were
analyzed by the MTT colorimetric assay. For the cytotoxicity
assay 5000 cells were seeded in each well of 96-well plates and
grown for 24 h. After that, the medium was replaced with
fresh medium containing the diﬀerent types of nanoparticles
in varying concentrations. After cultivation again for 24 h or
120 h (in the case of 120 h, the medium was supplemented
with FBS (20 µL per well) after 72 h of incubation), 20 µL of
MTT dye solution (5 mg cm−3 in PBS) was added to each well.
After 4 h of incubation at 37 °C and 5% CO2, the medium was
removed, the cells were washed with fresh medium, and for-
mazan crystals were dissolved in 100 µL of DMSO. The absor-
bance of each well was read on a microplate reader (Biotek
ELX800) at 570 nm. The spectrophotometer was calibrated to
zero absorbance using culture medium without cells. The
relative cell viability (%) related to control wells containing
cell culture medium without nanoparticles was calculated by
[A]test/[A]control × 100. Each measurement was repeated at
least five times to obtain the mean values and the standard
deviation.
3. Results and discussion
3.1. Eu:GdVO4 nanocrystals
Several Eu-doped GdVO4 samples having diﬀerent Eu content
(Eu/Eu + Gd mol ratio = 2, 5, 10, 15%) were synthesized in
order to optimize the luminescent properties of these nano-
phosphors. Irrespective of the Eu content, all samples showed
similar morphological (Fig. S1†) and structural characteristics
(Fig. S2†), which are illustrated here for the case of
Eu0.10Gd0.90VO4 chosen as a representative example. This
sample consisted of almost equiaxial nanocrystals (Fig. 1, top),
which, according to XRD (Fig. 2), crystallized into the tetra-
gonal GdVO4 structure (ICDD file no. 01-086-0996). The crystal-
lite size value estimated from this XRD pattern was similar
(54 nm) to the hydrodynamic diameter (70 nm) (Table 1)
obtained from DLS measurements (Fig. S3†), indicating that
the nanocrystals presented monocrystalline character and that
they do not aggregate in aqueous dispersion.
FTIR spectroscopy was used to gain additional information
on samples composition. Thus, the spectrum of the
Eu0.10Gd0.90VO4 nanoparticles (Fig. 3) displayed the absorp-
tions associated with vanadate anions (<1000 cm−1),19 along
with broad bands at about 3400 and 1650 cm−1 due to
adsorbed water, and some much weaker features in the
1500–1300 cm−1 region, which can be attributed to the presence
of carbonate anions coming from the adsorption of atmos-
pheric CO2.
10b TGA analyses (Fig. 4) revealed a total weight
loss of ∼6 wt% in the 30 °C to 700 °C temperature range due
to the release of such impurities (∼4 wt% of surface-adsorbed
water between 25 and 230 °C and ∼2 wt% of carbonate anions
at >250 °C). Since no additional absorptions could be observed
in the FTIR spectrum of the sample, the presence of EG
species on the nanoparticles surface, previously observed for
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other Ln-doped nanoparticles prepared in EG,13a can be dis-
carded in our case.
The photoluminescence properties of the Eu:GdVO4 nano-
crystals with diﬀerent Eu content were evaluated in order to
find the optimum nanophosphor. Fig. 5 (top) shows the exci-
tation spectrum recorded for the Eu0.10Gd0.90VO4 (10% Eu
content) nanophosphors monitored at the most intense Eu3+
emission band (618 nm). As observed, it consisted of a strong
broad band centered at 274 nm, which has been previously
observed for several Eu-doped LnVO4 systems
20–23 and attribu-
ted to the overlapping of two charge transfer (CT) processes
involving Eu–O and V–O components, the former appearing at
higher energy21,24 or to electric and dipole-allowed transitions
from the 1A2 to the
1E and 1A1 excited states of the VO4
3− ion.20
Fig. 1 TEM micrographs of the Eu0.10Gd0.90VO4 nanocrystals unfunctionalized
(top) and functionalized with PAA (bottom).
Fig. 2 X-ray diﬀraction patterns for the Eu0.10Gd0.90VO4 nanocrystals unfunc-
tionalized and functionalized with PAA. The reference pattern for tetragonal
GdVO4 obtained from the ICDD ﬁle is also included.
Table 1 Crystallite size, hydrodynamic diameter and zeta potential (measured
at pH = 6.95) of Eu:GdVO4 nanocrystals unfunctionalized and functionalized
with AMD and PAAa
Samples
Hydrodynamic
diameter/DLS (nm)
Zeta potential
(mV)
Crystallite
size (nm)
Eu:GdVO4 70 (20) −27.4 54
Eu:GdVO4-AMD 134 (55) +39.5 —
Eu:GdVO4-PAA 60 (25) −44.8 62
a The standard deviations are shown in parentheses.
Fig. 3 Infrared spectra obtained for the Eu0.10Gd0.90VO4 nanocrystals unfunc-
tionalized and functionalized with AMD (top) and PAA (bottom). The spectra of
amino-dextran and polyacrylic acid polymers are also included for comparison.
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Some other bands resulting from f–f transitions of Eu3+ were
also found (inset in Fig. 5, top), which were much weaker than
those due to the CT processes, indicating that the excitation of
Eu3+ is more eﬃcient through the energy transfer band. Upon
excitation at this band (λex = 274 nm), the characteristic tran-
sition lines from the excited 5D0 level of Eu
3+ were detected
(Fig. 5, bottom). As expected for this material,24 the two most
intense bands are those originating from 5D0–
7F1 (593 nm)
and 5D0–
7F2 (618 nm) transitions, respectively, which were
located in the 580–620 nm region. It should be noted that the
most intense emission (5D0–
7F2 transitions), which appeared
split into two bands at 614 and 618 nm due to the crystal
field,20,21 showed a relative intensity much higher than that of
the 5D0–
7F1 transitions, indicating that the Eu
3+ cations are
located in crystallographic sites with no inversion center as
those with D2d symmetry occupied by Gd
3+ cations in tetra-
gonal GdVO4.
24 In Fig. 5 (bottom), it can be also observed that
the increase of the Eu doping level from 2 to 10% gave rise to
an important increase of the intensity of the emission bands
as a consequence of the increase of the number of emission
centers. However, such intensity decreased significantly when
the Eu content was increased to 15% indicating the presence
of a concentration quenching eﬀect. Thus, the Eu doping level
driving the strongest emission for our nanocrystals was 10%
(Eu/Eu + Gd) mol ratio, which is within the range previously
reported for Eu:GdVO4 nanorods
24 and other more hetero-
geneous nanostructures.20 Therefore, this sample was selected
for further studies.
3.2. Functionalization of Eu:GdVO4 nanocrystals
The Eu0.10Gd0.90VO4 nanocrystals were functionalized with
amino and carboxylate groups according to the two step and
one-pot procedures described in the Experimental section.
The incorporation of AMD polysaccharide into the
Eu0.10Gd0.90VO4 nanocrystals following the two step method
(functionalization was performed on previously synthesized
nanocrystals) was substantiated by FTIR spectroscopy. Thus,
the spectrum of the AMD functionalized nanocrystals (Fig. 3,
top) displayed the absorption characteristics of the non-func-
tionalized Eu:GdVO4 nanocrystals above described, along with
some other bands in the 1000–1500 cm−1 region and two
weaker features at around 2930 cm−1, which were also detected
for the amino-dextran polymer (Fig. 3, top) and are mainly due
to the O–C–O vibrations (1000–1200 cm−1) and the CH2
stretching vibrations of dextran, respectively,25 indicating the
eﬀective absorption of AMD molecules on the surface of the
nanoparticles.
Thermogravimetric analyses were used to estimate the
amount of amino-dextran species attached to the nanoparti-
cles surface. The TGA curve obtained for the Eu–GdVO4 nano-
crystals after AMD adsorption is reported in Fig. 4. It is seen
that a mass loss occurred in a wide temperature range from
room temperature to 700 °C which could be divided into two
steps. The first one (∼2 wt%) due to the water release took
place from room temperature to about 230 °C. It should be
noted that the amount of adsorbed water was lower in this
case than for the non-functionalized nanoparticles. A second
weight loss of ∼8 wt% took place from 230 °C to 700 °C which
is associated with the decomposition of the adsorbed organic
species, mainly AMD polymers and carbonate anions coming
from CO2 adsorption. Since the weight content corresponding
to the latter is ∼2% (as determined above for non-
Fig. 4 TGA curve analyses for the Eu0.10Gd0.90VO4 nanocrystals unfunctiona-
lized and functionalized with AMD and PAA.
Fig. 5 Excitation (λem = 618 nm) spectrum for Eu0.10Gd0.90VO4 nanocrystals
(top) and emission (λex = 274 nm) spectra of the Eu-doped GdVO4 with diﬀerent
Eu content (bottom).
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functionalized samples), it can be considered that the amount
of AMD species on the surface of the nanoparticles corres-
ponded to ∼6 wt%.
The success of the functionalization was also confirmed by
the surface charge reversal observed for the AMD functiona-
lized nanoparticles in aqueous suspensions (Z potential =
39.5 mV) when compared with the untreated ones (Z potential
= −27.4 mV) (Table 1).
The functionalization of the Eu0.10Gd0.90VO4 nanocrystals
with PAA polymers was carried out through a one-pot pro-
cedure involving the addition of PAA (2 mg cm−3) to the start-
ing solutions prior to the aging process required for the
nanoparticles synthesis. Such addition was found to have an
important eﬀect on morphological characteristics of the final
nanocrystals. Thus, almost equiaxial nanocrystals were
obtained (Fig. 1, bottom) which were more homogeneous than
those formed in the absence of PAA (Fig. 1, top). These nano-
crystals also consisted of tetragonal GdVO4 (Fig. 2) and were
monocrystalline as indicated by the crystallite size value esti-
mated from their XRD pattern, which was similar (62 nm) to
the mean hydrodynamic diameter (60 nm) (Table 1) obtained
from DLS (Fig. S3†).
In addition to the vibrational features due to the non-func-
tionalized nanocrystals, the FTIR spectrum obtained for the
PAA functionalized nanocrystals (Fig. 3, bottom) displayed
some extra signals that confirm the presence of PAA on the
surface of the nanoparticles. Thus, the bands around 1400 and
1550 cm−1 can be ascribed to the symmetric and asymmetric
stretching frequencies of the carboxylate ion, respectively,
which must be mainly due to the PAA species since their inten-
sity is much higher than that of the carbonate impurities
appearing in the same region for the unfunctionalized sample.
For the same reason, the possible presence of such carbonate
ions in the PAA-functionalized particles cannot be analysed on
the basis of these data. It should be noted that the carboxylate
bands appeared to be shifted to lower frequencies for pure
PAA, which suggests that the carboxylate functional groups of
the polymer are protonated, whereas in the nanoparticles they
are mainly ionized.26
The TGA curve obtained for the PAA functionalized nano-
particles is shown in Fig. 4. As observed, the total mass loss
was similar (∼9 wt%) to that observed after functionalization
with AMD (10%) and also took place in two steps. The first one
(25–230 °C), due to the water release, was higher (∼4 wt%)
than that associated with the AMD-functionalized nanoparti-
cles (∼2 wt%) but similar to that obtained for the unfunctiona-
lized ones (∼4 wt%). The second loss (∼5 wt%) occurred in the
same temperature range observed for the AMD-functionalized
nanoparticles (250–700 °C) and was also attributed to the
decomposition of mainly PAA, although the presence of a
small amount of carbonate anions cannot be discarded. The
success of the functionalization was also confirmed by the
increase of the surface charge value observed for the PAA func-
tionalized nanoparticles (Z potential = −44.8 mV) when com-
pared with the unfunctionalized nanocrystals (Z potential =
−27.4 mV) (Table 1).
The eﬀects of functionalization on the photoluminescence
(PL) properties of the Eu0.10Gd0.90VO4 nanophosphors were
also investigated. Fig. 6 displays the excitation (monitored at
618 nm) and emission (λex = 274 nm) spectra of the functiona-
lized samples along with the spectra corresponding to the
unfunctionalized sample for comparison. As observed, the
intensity of the CT band decreased for both functionalized
samples when compared with the unfunctionalized nanoparti-
cles (Fig. 6, top). A similar behavior was also detected for the
emission bands (Fig. 6, bottom). These eﬀects might be
ascribed to the presence of organic species on the nanoparti-
cles surface, which are known to aﬀect the luminescence pro-
perties of Eu since they increase the probability of non-
radiative transition (not eﬃcient transfer) due to their high
vibrational frequencies,27 resulting in a partial quenching of
luminescence.
To confirm this suggestion, lifetimes of 5D0 Eu manifold
have been measured under the excitation provided by the
second harmonic of a pulsed Nd:YAG laser (λexc = 532 nm).
This excitation eﬃciently populates the 5D1 multiplet (
7F0 →
5D1 transition) which then populates the
5D0 state via non-
radiative relaxation,28 from where the diﬀerent visible emis-
sions originate. It has been verified that the emission spectra
under this excitation are coincident with those obtained after
274 nm excitation as shown in Fig. 6. The normalized
Fig. 6 Excitation spectra (λem = 618 nm) (top) and emission spectra (λex =
274 nm) (bottom) recorded for unfunctionalized and functionalized
Eu0.10Gd0.90VO4 nanoparticles. Inset: photographs of an aqueous dispersion of
Eu0.10Gd0.90VO4 functionalized with PAA under UV (λ = 312 nm) illumination.
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temporal decays of the 5D0 level, measured at λem = 618 nm
(5D0 →
7F2 transition), for the unfunctionalized and the two
functionalized samples are shown in Fig. 7. The emission life-
times (τ) included in the inset of this figure have been evalu-
ated from these measurements as:29
τ ¼
ð1
0
t IðtÞdt
ð1
0
IðtÞdt
As observed, the emission lifetime obtained for the functio-
nalized samples was lower (0.8 ms, for the PAA functionalized
sample and 0.74 ms, for the AMD functionalized sample) than
that of the functionalized one (0.94 ms), confirming the
partial luminescence quenching resulting from the
functionalization process. It can be also observed that the life-
time decrease is slightly higher for the AMD-functionalized
sample than for the PAA-functionalized sample, which
retained a strong red luminescence when illuminated with UV
radiation (312 nm), as is illustrated in the inset of Fig. 6.
Therefore, these modified Eu-doped GdVO4 nanocrystals may
be used as optical biolabels for “in vitro” applications.
3.3. Colloidal stability
The functionalization with AMD by subsequent covering of the
Eu0.10Gd0.90VO4 nanoparticles previously obtained had a sig-
nificant eﬀect on the hydrodynamic diameter of the nanocrys-
tals measured by DLS (Fig. S3†). Thus, the value of this
magnitude obtained from freshly prepared dispersions in
water (pH = 6.95) was clearly higher (134 nm) than that
obtained from the unfunctionalized nanocrystals (70 nm)
(Table 1), which cannot be only explained by the existence of
AMD on the nanoparticles surface but most probably by the
presence of a weak aggregation process since no changes in
particle size were observed under the TEM microscope after
functionalization (Fig. S4†). It should be noted that the
value of hydrodynamic diameter remained almost constant
(123 nm) after keeping the dispersion undisturbed for
2 weeks indicating that the above suggested aggregation
should take place in the course of functionalization. In spite of
the aggregation, no sedimentation was detected in the sus-
pensions after at least 2 days, as indicated by the lack of vari-
ation of the intensity of the band due to vanadate ions
appearing at ∼270 nm in their UV-visible absorption spectrum
(Fig. 8). A similar behavior was observed for water suspensions
(pH = 6.95) of the Eu0.10Gd0.90VO4 nanoparticles functiona-
lized with PAA, whose UV-visible absorption spectrum also
remained constant on aging up to at least 2 days (Fig. 8). It is
important to mention that for the latter system, the hydro-
dynamic diameter measured for the suspension kept undis-
turbed for two weeks was quite similar (55 nm) to that
obtained for fresh dispersions (60 nm) indicating the absence
of particle aggregation during this period of time and the
higher colloidal stability of the Eu0.10Gd0.90VO4–PAA nano-
phosphors. The stability of the latter sample in one of the most
used biological buﬀer media (MES at pH = 6.5) and in com-
pleted cell culture media (DMEM + FBS) was also addressed. It
was found that in MES buﬀer, no sedimentation took place
during at least 4 days of aging (Fig. 9, bottom) and that the
average hydrodynamic diameter of the nanoparticles remained
unaltered (60 nm) after the same period of time (Fig. 9, top),
whereas in completed cell culture media (DMEM + FBS), a
slight increase in this magnitude was detected (78 nm).
Owing to this excellent colloidal stability of the
Eu0.10Gd0.90VO4–PAA nanophosphors, they were selected for
studies on their biocompatibility and suitability as MRI con-
trast agents.
3.4. Relaxation time studies
The measurement of the longitudinal (T1) and transversal (T2)
proton relaxation times as a function of the gadolinium ion
concentration at 1.5 T gave for the PAA functionalized Eu0.10-
Gd0.90VO4 sample r1 and r2 values of 0.77 and 2.28 s
−1 mM−1,
Fig. 7 Temporal evolution of the 5D0 →
7F2 luminescence measured after
pulsed excitation to the vanadate group in the Eu:GdVO4 nanocrystals unfunc-
tionalized and functionalized with AMD and PAA.
Fig. 8 Evolution with aging time of the UV-visible absorption spectra recorded
for unfunctionalized and functionalized Eu0.10Gd0.90VO4 nanocrystals dispersed
in milliQ water (pH = 6.95).
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respectively (Fig. 10). It must be first mentioned that these
values are quite similar to those obtained for the unfunctiona-
lized sample (Fig. S5†), which indicates that the functionali-
zation process had no important eﬀect on the magnetic
behavior of this material. It must be also noted that the r1
value measured for our nanoparticles is among the highest
values previously reported for this system (between 0.438 and
0.76 s−1 mM−1),13b,14 although the applied field used for the
measurements was diﬀerent in all cases (0.5,14 1.5 (this work)
and 4.7 T13b), which complicates a proper comparison of these
values since they are aﬀected by these parameters among other
factors.30 Nevertheless, the r2/r1 ratio obtained for our nano-
particles was rather high (∼3) precluding their use as positive
contrast agents, which requires r2/r1 values close to unity.
1h,9a
However, the MRI phantom analysis (Fig. 11) clearly mani-
fested T2 susceptibility eﬀects at higher magnetic fields (9.4 T)
indicating that our Eu:GdVO4 nanoparticles may be used as
negative (T2-weighted) MRI contrast agents.
3.5. Biocompatibility studies of Eu:GdVO4 nanocrystals
functionalized with PAA
Biocompatibility studies were performed by evaluating the cell
viability of Vero cells by the MTT assay.31 This assay relies on
the mitochondrial activity of fibroblasts and represents a
parameter for their metabolic activity. The MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay
is a simple non-radioactive colorimetric assay to measure cell
cytotoxicity, proliferation, or viability. MTT is a yellow, water-
soluble tetrazolium salt. Metabolically active cells are able to
convert this dye into a water-insoluble dark-blue formazan by
reductive cleavage of the tetrazolium ring. Formazan crystals,
then, can be dissolved in an organic solvent such as dimethyl-
sulphoxide (DMSO) and quantified by measuring the
Fig. 9 Hydrodynamic diameter obtained by DLS measurements (top) and
evolution with aging time of the UV-visible absorption spectra (bottom) for the
PAA functionalized Eu0.10Gd0.90VO4 nanocrystals in biological buﬀer media
(MES at pH = 6.5).
Fig. 10 Proton relaxivities (r1 and r2) measured for the Eu0.10Gd0.90VO4 nano-
phosphor functionalized with PAA at 1.5 T.
Fig. 11 T2 parametric MRI phantom images (9.4 T) of Eu0.10Gd0.90VO4 nano-
phosphor functionalized with PAA showing transversal relaxation times of nano-
particle suspensions: (a) control (water); (b–f ) serial dilutions (0.1, 0.05, 0.025,
0.0125, 0.00625 mg cm−3).
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absorbance of the solution at 550 nm, and the resultant value
is related to the number of living cells. The metabolic activity
and proliferation of fibroblasts were thus measured after
24 hours culture, and showed negligible toxicity eﬀects
(Fig. 12) with viability percentages >80% for concentrations up
to 0.5 mg cm−3. Similar results were obtained when the fibro-
blasts proliferation was measured after longer incubation
times (120 hours), which are closer to the final application of
this kind of nanoparticles. These MTT assay results show the
possibility of using this kind of nanoparticles for long term
fluorescent or MRI analysis and tracking into cells or tissues.
However, a deeper viability and toxicological study should be
performed to guarantee the lack of adverse eﬀects on the
organism.
4. Conclusions
Eu-doped GdVO4 nanocrystals (∼70 nm) with almost equiaxial
morphology have been synthesized by a homogenous precipi-
tation process using ethylene glycol–water as a solvent at rela-
tively low temperature. These nanoparticles consisted of single
crystals with tetragonal structure. Luminescence measurement
reveals that the optimum Eu doping level was 10% (Eu/Eu +
Gd) molar ratio. These nanocrystals were successfully functio-
nalized with amino (two steps) and carboxylate (one-pot)
groups provided by amino-dextran polymers (AMD) and poly-
acrylic acid (PAA), respectively, which allows further conju-
gation with biologically active molecules (such as antibodies,
peptides and proteins). After functionalization, the
Eu0.10Gd0.90VO4 samples retained a strong luminescence
under UV illumination (312 nm). It was also found that the
functionalization with AMD gave rise to a certain degree of
aggregation, which was not observed for the PAA-functiona-
lized sample. The latter also showed a very high colloidal stabi-
lity in neutral water, biological buﬀer (MES, pH = 6.5) and in
cell culture media dispersions as well as no significant toxicity
for cells in concentrations up to 0.5 mg cm−3. These properties
make the PAA-functionalized Eu–GdVO4 nanocrystals good
candidates as optical biolabels for “in vitro” applications.
Finally, magnetic relaxivity measurements and phantom ana-
lyses revealed that they may be used as negative (T2-weighted)
MRI contrast agents.
Acknowledgements
This work has been supported by Junta de Andalucía (grant
FQM6090), the Spanish CICYT (grant MAT2011-23593), Fondo
Social Europeo and ERC-Starting Grant NANOPUZZLE. Nuria
O. Nuñez wants to thank the Spanish National Research
Council for financial support (PIE-200960I127). The authors
also want to thank Prof. Fernando Cussó for his help for life-
time measurements.
References
1 (a) G. Tian, Z. Gu, X. Liu, L. Zhou, W. Yin, L. Yan, S. Jin,
W. Ren, G. Xing, S. Li and Y. Zhao, J. Phys. Chem. C, 2011,
115, 23790; (b) J. W. Mulder, A. W. Griﬃoen, G. J. Strijkers,
D. P. Cormode, K. Nicolay and Z. A. Fayad, Nanomedicine,
2007, 2, 307; (c) R. Kumar, M. Nyk, T. Y. Ohulchanskyy,
C. A. Flask and P. N. Prasad, Adv. Funct. Mater., 2009, 19,
853; (d) G. K. Das, B. C. Heng, S. C. Ng, T. White, J. S. Loo,
L. D’Silva, P. Padmanabhan, K. K. Bhakoo, S. T. Selvan and
T. Y. Tan, Langmuir, 2010, 26, 8959; (e) J. Ryu, H. Y. Park,
K. Kim, H. Kim, J. H. Yoo, M. Kang, K. Im, R. Grailhe and
R. Song, J. Phys. Chem. C, 2010, 114, 21077; (f ) Y. I. Park,
J. H. Kim, K. T. Lee, K. S. Jeon, H. B. Na, J. H. Yu,
H. M. Kim, N. Lee, S. H. Choi, S. I. Baik, H. Kim, S. P. Park,
B. J. Park, Y. W. Kim, S. H. Lee, S. Y. Yoon, I. C. Song,
W. K. Moon, Y. D. Suh and T. Hyeon, Adv. Mater., 2009, 21,
4467; (g) X. Yu, Y. Shan, G. Li and K. Chen, J. Mater. Chem.,
2011, 21, 8104; (h) N. J. J. Johnson, W. Oakden,
G. J. Stanisz, R. S. Prosser and F. C. J. M. van Veggel, Chem.
Mater., 2011, 23, 3714; (i) M. He, P. Huang, C. Zhang,
H. Hu, C. Bao, G. Gao, R. He and D. Cui, Adv. Funct. Mater.,
2011, 21, 4470; ( j) L. Zhou, Z. Gu, X. Liu, W. Yin, G. Tian,
L. Yan, S. Jin, W. Ren, G. Xing, W. Li, X. Chang, Z. Hu and
Y. Zhao, J. Mater. Chem., 2012, 22, 966.
2 F. Wang, X. Chen, Z. Zhao, S. Tang, X. Huang, C. Lin,
C. Cai and N. Zheng, J. Mater. Chem., 2011, 21, 11244.
3 Z. Liu, G. Yi, H. Zhang, J. Ding, Y. Zhang and J. Xue, Chem.
Commun., 2008, 694.
4 Z. Y. Ma, D. Dosev, M. Nichkova, S. J. Gee, B. D. Hammock
and I. M. Kennedy, J. Mater. Chem., 2009, 19, 4695.
5 Y. Zhang, G. K. Das, R. Xu and T. T. Tan, J. Mater. Chem.,
2009, 19, 3696.
6 J. L. Bridot, A. C. Faure, S. Laurent, C. Rivière, C. Billotey,
B. Hiba, M. Janier, V. Josser, J. J. Coll, L. V. Elst, R. Muller,
S. Roux, P. Perriat and O. Tillement, J. Am. Chem. Soc.,
2007, 129, 5076.
Fig. 12 Cytotoxicity proﬁles of the Eu0.10Gd0.90VO4–PAA nanoparticles with
VERO cells as determined by the MTT assay. Percentage of viability of cells was
expressed relative to control cells (n = 5). Results are represented as mean ± stan-
dard deviations.
Dalton Transactions Paper
This journal is © The Royal Society of Chemistry 2013 Dalton Trans., 2013, 42, 10725–10734 | 10733
Pu
bl
ish
ed
 o
n 
21
 M
ay
 2
01
3.
 D
ow
nl
oa
de
d 
by
 C
en
tro
 d
e 
In
ve
sti
ga
ci
on
es
 C
ie
nt
ifi
ca
s I
sla
 d
e 
la
 C
ar
tu
ja 
(C
IC
IC
) o
n 3
0/0
4/2
01
4 0
8:2
9:3
9. 
View Article Online
7 F. Evanics, P. R. Diamente, F. C. J. M. van Veggel,
G. J. Stanisz and R. S. Prosser, Chem. Mater., 2006, 18,
2499.
8 K. M. L. Taylor, J. S. Kim, W. J. Rieter, H. An and W. Lin,
J. Am. Chem. Soc., 2008, 130, 2154.
9 (a) H. Hifumi, S. Yamaoka, A. Tanimoto, D. Citterio and
K. Suzuki, J. Am. Chem. Soc., 2006, 128, 15090;
(b) M. F. Dumont, C. Baligand, Y. Li, E. Knowles,
M. W. Meisel, G. A. Walter and D. R. Talham, Bioconjugate
Chem., 2012, 23, 951; (c) W. Ren, G. Tian, L. Zhou, W. Yin,
L. Yan, S. Jin, Y. Zu, S. Li, Z. Gu and Y. Zhao, Nanoscale,
2012, 4, 3754.
10 (a) D. Giaume, M. Poggi, D. Casanova, G. Mialon, K. Lahlil,
A. Alexandrou, T. Gacoin and J. P. Boilot, Langmuir, 2008,
24, 11018; (b) L. Yang, G. Li, W. Hu, M. Zhao, L. Sun,
J. Zheng, T. Yan and L. Li, Eur. J. Inorg. Chem., 2011, 2211;
(c) B. K. Gupta, V. Rathee, T. N. Narayan, P. Thanikaivelan,
A. Saha, S. P. Singh, V. Shanker, A. A. Narti and
P. M. Alayan, Small, 2011, 7, 1767.
11 (a) M. Gu, Q. Liu, S. Mao and C. Chang, Cryst. Growth Des.,
2008, 8, 1422; (b) Y. Zheng, H. You, G. Jia, K. Liu, Y. Song,
M. Yang and H. Zhang, Cryst. Growth Des., 2009, 9, 5101;
(c) Y. Su, L. Liping, G. Li, J. Liu, X. Chen, W. Hu and G. Liu,
J. Nanosci. Nanotechnol., 2010, 10, 1877.
12 R. Calderon-Villajos, C. Zaldo and C. Cascales, CrystEng-
Comm, 2012, 14, 2756.
13 (a) N. Shanta Singh, R. S. Ningthoujam, G. Phaomei,
S. Dorendrajit, A. Vinu and R. K. Vatsa, Dalton Trans., 2012,
41, 4412; (b) W. Yin, L. Zhou, Z. Gu, G. Tian, S. Jin, L. Yan,
X. Liu, G. Xing, W. Ren, F. Liu, Z. Pan and Y. Zhao, J. Mater.
Chem., 2012, 22, 6974.
14 X. Kang, D. Yang, Y. Dai, M. Shang, Z. Cheng, X. Zhang,
H. Lian, P. Ma and J. Lin, Nanoscale, 2013, 5, 253.
15 X. Kang, D. Yang, P. Ma, Y. Dai, M. Shang, D. Geng,
Z. Cheng and J. Lin, Langmuir, 2013, 29, 1286.
16 D. K. Chatterjee, M. K. Gnanasammandhan and Y. Zhang,
Small, 2010, 6, 2781.
17 B. J. Shen, L. D. Sun, J. D. Zhu, L. H. Wei, H. F. Sun and
C. H. Yan, Adv. Funct. Mater., 2010, 20, 3708.
18 R. C. Rodríguez, J. M. Bolivar, G. Volpato, M. Filice,
C. Godoy, R. Fernandez-Lafuente and J. M. Guisan, J. Bio-
technol., 2009, 144, 113.
19 L. Yang, L. Li, M. Zhao and G. Li, Phys. Chem. Chem. Phys.,
2012, 14, 9956.
20 S. Tang, M. Huang, J. Wang, F. Yu, G. Shang and J. Wu,
J. Alloys Compd., 2012, 513, 474.
21 K. Riwotzki and M. Haase, J. Phys. Chem. B, 1998, 102, 10129.
22 N. Shanta Singh, R. S. Ningthoujam, D. L. Romila,
N. Yaiphaba, V. Sudarsan, S. Dorendrajit Singh, R. K. Vatsa
and R. Tewari, J. Appl. Phys., 2008, 104, 104307.
23 M. Kim and S. Kang, J. Mater. Res., 2007, 22, 1.
24 L. Yang, G. Li, M. Zhao, J. Zheng, X. Guan and L. Li, Nano-
technology, 2012, 23, 245602.
25 W. Chen, P. Yi, Y. Zhang, L. Zhang, Z. Deng and Z. Zhang,
ACS Appl. Mater. Interfaces, 2011, 3, 4085.
26 L. J. Kirwan, P. F. Fawell and W. Bronswijk, Langmuir, 2003,
19, 5802.
27 P. Yang, S. Huang, D. Kong, J. Lin and H. Fu, Inorg. Chem.,
2007, 46, 3203.
28 S. Rodríguez-Liviano, F. J. Aparicio, T. C. Rojas,
A. B. Hungría, L. E. Chinchilla and M. Ocaña, Cryst. Growth
Des., 2012, 12, 635.
29 M. Inokuti and F. J. Hirayama, Chem. Phys., 1965, 43, 1978.
30 P. Caravan, C. T. Farrar, L. Frullano and R. Uppal, Contrast
Media Mol. Imaging, 2009, 4, 89.
31 T. J. Mosmann, J. Immunol. Methods, 1993, 95, 55.
Paper Dalton Transactions
10734 | Dalton Trans., 2013, 42, 10725–10734 This journal is © The Royal Society of Chemistry 2013
Pu
bl
ish
ed
 o
n 
21
 M
ay
 2
01
3.
 D
ow
nl
oa
de
d 
by
 C
en
tro
 d
e 
In
ve
sti
ga
ci
on
es
 C
ie
nt
ifi
ca
s I
sla
 d
e 
la
 C
ar
tu
ja 
(C
IC
IC
) o
n 3
0/0
4/2
01
4 0
8:2
9:3
9. 
View Article Online
